TruScreen Completes Oversubscribed Placement
25/05/2026 08:30 NZST, OFFERP
NZX/ASX Announcement
25 May 2026
TruScreen Completes Oversubscribed Placement
TruScreen Group Limited (NZX/ASX:TRU) (TruScreen or TRU or Company) is pleased to advise that further to the announcement of 21 May 2026 “TruScreen announces the opening of a NZ$2.9m capital raise”, the Company has received firm commitments from both new and existing investors for an initial placement to institutional and other select investors ("Placement") of approximately 130 million shares at NZ$0.014/A$0.012 per share to raise approximately NZ$1.82m / A$1.52m before costs.
The Placement was oversubscribed by approximately NZ$820,000. Given that the demand in the Placement was higher than the Company's available placement capacity, the Company has agreed with Placement participants to implement a partial deferred settlement for the Placement as follows:
1. Approximately 110 million shares will be issued under the Company’s existing 15% placement capacity in a tranche 1 issue on 1 June 2026.
2. Approximately 20 million shares will be issued in tranche 2, subject to receiving an NZX waiver to permit the later settlement time and shareholder approval at a meeting to be held on or around 7 July 2026.
3. The Company will issue one free attaching option, for each two (2) new shares issued under the Placement (including shares issued under both tranche 1 and tranche 2), with an exercise price NZ$0.014 /A$0.012 and an expiry date two years from the date of issue, subject to shareholder approval at the shareholder meeting to be held on or around 7 July 2026.
The placement was successfully managed by joint lead managers, S P Corporate Advisory Pty Limited and Erity Capital Pty Limited.
The renounceable rights issue (see Rights Issue Offer Document lodged with NZX/ASX on 21 May 2026), will open on 29 May 2026 providing eligible shareholders on the record date of 28 May 2026, the opportunity to take up their entitlement of one (1) share for every five (5) held at a price of NZ$0.013 /A$0.011. Documents for the Renounceable Rights Issue will be mailed to shareholders on 29 May 2026.
Tony Ho Chairman commented, “we are pleased with the strong support that we have received for this placement. In addition to the growth of our distributor business, conversion of just one of the screening programme submissions under UNITAID’s Global Cervical Cancer Elimination Call could be transformational for the Company.”
In the event shareholders do not receive application forms for the Renounceable Rights Offer please contact the share registry MUFG Corporate Markets:applications.nz@cm.mpms.mufg.com (Please use “TruScreen Rights Offer”) as the subject of the email, or Telephone +64 9 375 5998 or contact the Company Secretary, contact details below.
This announcement has been approved by the Board.
Ends
Guy Robertson
Company Secretary
Tel: +61 407 983 270
Email: guyrobertson@truscreen.com
For more information, visit www.truscreen.com or contact:
Tony Ho
Executive Chairman
tonyho@truscreen.com
Guy Robertson
Chief Financial Officer
guyrobertson@truscreen.com
Jack Zhang
Media & Investor Relations
jack@sparkplus.org